Nyxoah SA
Nyxoah SA is a Healthcare company operating in Medical Instruments & Supplies with a $156.9M market cap.
Most recent earnings call: Q1 FY26 on May 12, 2026.
15 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks NYXH's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 6/10 quarters with 50% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for NYXH.
$ curl https://api.spokenalpha.com/v1/companies/NYXHFAQ
Spoken Alpha indexes NYXH's earnings call transcripts at https://spokenalpha.com/companies/NYXH. Each call links to attributed speakers and parsed analyst Q&A. Nyxoah SA's own investor relations page is at https://investors.nyxoah.com/.
Nyxoah SA (NYXH) held its most recent earnings call on 2026-05-12, covering fiscal Q1 2026.
Nyxoah SA (NYXH) operates in the Healthcare sector (Medical Instruments & Supplies industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.69 | $3.44 | +7.4% | -5.7% | -2.8% |
| Q4 FY2026 | $3.71 | $3.53 | +5.1% | +0.3% | +1.1% |
| Q3 FY2026 | $3.41 | $3.44 | -1.0% | +0.2% | +3.0% |
| Q2 FY2026 | $3.32 | $3.44 | -3.4% | +2.2% | +1.3% |
| Q1 FY2025 | $3.60 | $3.60 | +0.1% | +3.0% | +0.9% |
| Q4 FY2025 |
| $3.60 |
| $3.54 |
| +1.8% |
| +2.9% |
| +4.3% |
| Q3 FY2025 | $3.60 | $3.42 | +5.4% | -6.1% | -3.2% |
| Q2 FY2025 | $3.33 | $3.45 | -3.4% | -7.6% | -6.7% |
| Q1 FY2024 | $3.76 | $3.48 | +8.0% | -3.4% | -1.0% |
| Q4 FY2024 | $3.47 | $3.57 | -2.9% | -2.9% | -4.5% |